BLADX
Price
$9.49
Change
-$0.02 (-0.21%)
Updated
Jun 6 closing price
Net Assets
787.04M
BLDRX
Price
$9.51
Change
-$0.02 (-0.21%)
Updated
Jun 6 closing price
Net Assets
787.04M
Interact to see
Advertisement

BLADX vs BLDRX

Header iconBLADX vs BLDRX Comparison
Open Charts BLADX vs BLDRXBanner chart's image
BlackRock Managed Income Investor A
Price$9.49
Change-$0.02 (-0.21%)
VolumeN/A
Net Assets787.04M
BlackRock Managed Income K
Price$9.51
Change-$0.02 (-0.21%)
VolumeN/A
Net Assets787.04M
BLADX vs BLDRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BLADX vs. BLDRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLADX is a Buy and BLDRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BLADX (787M) and BLDRX (787M) have equal amount of cash in the bank . BLDRX pays higher dividends than BLADX: BLDRX (5.82) vs BLADX (5.53). BLADX was incepted earlier than BLDRX: BLADX (18 years) vs BLDRX (18 years). BLADX (0.94) is less costly to investors than BLDRX (0.64). BLADX (80.00) and BLDRX (80.00) have comparable annual turnover. BLADX has a lower initial minimum investment than BLDRX: BLADX (1000) vs BLDRX (5000000). BLDRX (7.03) and BLADX (6.83) have marching annual gain over last year. BLDRX return over 5 years is better than : 20.53 vs. BLADX (18.72).
BLADXBLDRXBLADX / BLDRX
Total Expense Ratio0.720.42171%
Annual Report Gross Expense Ratio0.940.64147%
Fund Existence18 years18 years-
Gain YTD3.7593.773100%
Front Load4%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets787M787M100%
Annual Yield % from dividends5.535.8295%
Returns for 1 year6.837.0397%
Returns for 3 years16.4317.5194%
Returns for 5 years18.7220.5391%
Returns for 10 years43.0347.5890%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAFGX45.540.32
+0.71%
American Funds AMCAP R6
EMGCX23.57N/A
N/A
Allspring Emerging Markets Equity C
HSGFX6.52N/A
N/A
Hussman Strategic Market Cycle Fund
BRKSX15.21N/A
N/A
MFS Blended Research Em Mkts Eq R2
MEMSX8.38N/A
N/A
Mercer Emerging Markets Equity I